NCT06796595

Brief Summary

Pudendal and inferior cluneal neuralgias are responsible for chronic pelvicperineal pain. These two neuralgias are associated in approximately 25% of cases. In the event of failure of first-line multimodal medical treatment, a mini-invasive robot-assisted laparoscopic decompression can be proposed. These surgeries carry the risk of neurapraxia, leading to a temporary increase in neuropathic pain and numbness in the nerve sensitive area, a motoric or neurovegetative disturbance (pudendal).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
9mo left

Started Jan 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Jan 2025Jan 2027

First Submitted

Initial submission to the registry

January 22, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

January 23, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

January 22, 2025

Last Update Submit

January 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluate the 1-year effectiveness of a perioperative medical program on the characteristics of neuropathic pain related to postoperative neurapraxia, following robot-assisted laparoscopic neurolyses of the pudendal and inferior cluneal nerves

    Numeric pain scale (0 "no pain" to 10 "maximal pain")

    Pré-operatively, and then post-operatively : every day the first month, then once a week until the 4th month then at 1 year year after surgery

Secondary Outcomes (5)

  • Report all complications during the follow-up

    2 days, 4 months, 1 year after surgery

  • Evaluate the effect of the surgical technique on anxiety

    Pré-operatively, 2 days, 4 months, 1 year after surgery

  • Evaluate the effect of the surgical technique on depression

    Pré-operatively, 2 days, 4 months, 1 year after surgery

  • Evaluate the effect of the surgical technique on post-traumatic stress syndrome

    Pré-operatively, 2 days, 4 months, 1 year after surgery

  • Evaluate the impact on quality of life

    Pré-operatively, 2 days, 4 months, 1 year after surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This cohort study is a pilot study to evaluate the 1-year effectiveness of a perioperative medical program on the characteristics of neuropathic pain related to postoperative neurapraxia, following robot-assisted laparoscopic neurolyses of the pudendal and inferior cluneal nerves

You may qualify if:

  • Patients over 18 years old
  • Patients presenting a pudendal and/or inferior cluneal neuralgias with failure of the medical treatment
  • Patient having given consent after reading the information note

You may not qualify if:

  • Inoperable patients (contraindications to anesthesia or surgery) surgical contraindications)
  • Person deprived of liberty or under guardianship
  • Person under court protection
  • Pregnant or breast-feeding woman
  • Minors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UBOSGA

Bordeaux, 33000, France

RECRUITING

MeSH Terms

Conditions

Pudendal NeuralgiaNeuralgia

Condition Hierarchy (Ancestors)

Nerve Compression SyndromesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2025

First Posted

January 28, 2025

Study Start

January 23, 2025

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

January 31, 2027

Last Updated

January 28, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations